Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 45,474	$ 26,790
General and administrative	15,605	9,900
Total operating expenses	61,079	36,690
Loss from operations	(61,079)	(36,690)
Other income (expense):
Interest income	102	494
Interest expense	(1,202)	(1,012)
Other expense	(28)	(96)
Total other income (expense)	(1,128)	(614)
Net loss	(62,207)	(37,304)
Other comprehensive loss:
Unrealized loss on available-for-sale securities, net	(6)	(40)
Comprehensive loss	$ (62,213)	$ (37,344)
Net loss per share, basic and diluted	$ (2.29)	$ (3.97)
Weighted average shares of common stock outstanding, basic and diluted	27,188,864	9,404,188